Physician profile
Alexis E Pilato
NPI 1316389513
$5,599.81
in general payments reported to CMS, 2019-2025
16 companies · $571 in 2025
The $571 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.37 · 2020: $910 · 2021: $24.69 · 2022: $1,511 · 2023: $1,152 · 2024: $1,412 · 2025: $571.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,781 · Travel and Lodging: $1,355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,780.85 |
| Travel and Lodging | $1,354.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mid-Atlantic Surgical Systems, LLC | $2,504.13 | 2020-2023 | |
| Stryker Corporation | $1,522.52 | 2021-2025 | Pro, Gamma, Mako |
| Medartis INC. | $627.75 | 2022-2024 | Aptus |
| Arthrex, INC. | $457.80 | 2023 | |
| Endo Pharmaceuticals INC. | $71.10 | 2020-2023 | Xiaflex |
| Smith+Nephew, INC. | $65.82 | 2020-2025 | Pico |
| Cumberland Pharmaceuticals, INC. | $64.49 | 2022-2025 | Caldolor |
| Sonex Health, INC. | $61.59 | 2023 | Sx-One Microknife |
| Vertex Pharmaceuticals Incorporated | $44.87 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $38.30 | 2025 | Iovera, Zilretta, Exparel |
| Endo USA, INC. | $38.17 | 2025 | Xiaflex |
| Ethicon US, LLC | $38.07 | 2023 | Monocryl, Stratafix |
| Axogen | $18.37 | 2019 | |
| Ferring Pharmaceuticals INC. | $17.99 | 2022 | |
| Molnlycke Health Care US, LLC | $15.93 | 2025 | Mepilex Border Post-Op, Mepilex Border Post-Op Ag |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $12.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexis Pilato listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.